Medicare's drug-price negotiations will save the government billions in healthcare spending — but patients may not feel the benefits - McDermott+Consulting

Medicare’s drug-price negotiations will save the government billions in healthcare spending — but patients may not feel the benefits

Jeffrey Davis provided comments on Medicare drug pricing negotiations and rebates as part of the Inflation Reduction Act, in Business Insider.

READ MORE